BRCA1 Protein and Nucleolin Colocalize in Breast Carcinoma Tissue and Cancer Cell Lines

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2010 Jan 16

PMID 20075200

Citations 15

Authors

Natalie Tulchin

Monique Chambon

Gloria Juan

Steven Dikman

James Strauchen

Leonard Ornstein

Blase Billack

Nicholas T Woods

Alvaro N A Monteiro

Affiliations

Soon will be listed here.

Abstract

The breast and ovarian cancer susceptibility gene BRCA1 encodes a tumor suppressor. BRCA1 protein, which is involved in DNA damage response, has been thought to be found primarily in cell nuclei. In the present investigation, immunohistological studies of BRCA1 protein in frozen breast cancer tissue and MCF7 and HeLa cell lines revealed BRCA1 expression in both nucleoli and nucleoplasmic foci. Immunoelectron microscopic studies of estrogen-stimulated MCF7 cells demonstrated BRCA1 protein localization in the granular components of the nucleolus. Moreover, immunofluorescence of BRCA1 and nucleolin double-labeling showed colocalization in both nucleoli and nucleoplasmic foci in breast tumor cells and asynchronously growing MCF7 and HeLa cells. Multiparameter analysis of BRCA1 and nucleolin in relation to cell cycle position (DNA content) showed expression during G1-S and persistence of BRCA1 during G2/M. After gamma-irradiation of MCF7 cells, BRCA1 protein dispersed from nucleoli and nucleoplasmic foci to other nucleoplasmic sites, which did not colocalize with nucleolin. Small interfering RNA-mediated knockdown of BRCA1 protein resulted in decreased immunofluorescence staining, which was confirmed by Western blotting. The observed colocalization of BRCA1 and nucleolin raises new possibilities for the nucleoplasm-nucleolus pathways of these proteins and their functional significance.

Citing Articles

Identification of Hub of the Hub-Genes From Different Individual Studies for Early Diagnosis, Prognosis, and Therapies of Breast Cancer.

Alam M, Sultana A, Kibria M, Khanam A, Wang G, Haque Mollah M Bioinform Biol Insights. 2024; 18:11779322241272386.

PMID: 39239087 PMC: 11375675. DOI: 10.1177/11779322241272386.

Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma.

Paris E, Bahr J, Basu S, Barua A Cancers (Basel). 2023; 15(3).

PMID: 36765618 PMC: 9913361. DOI: 10.3390/cancers15030661.

The BRCA1 BRCT promotes antisense RNA production and double-stranded RNA formation to suppress ribosomal R-loops.

Chang C, Singh A, Li M, Guan L, Le N, Omabe K Proc Natl Acad Sci U S A. 2022; 119(50):e2217542119.

PMID: 36490315 PMC: 9897471. DOI: 10.1073/pnas.2217542119.

Nucleolin promotes Ang II‑induced phenotypic transformation of vascular smooth muscle cells via interaction with tropoelastin mRNA.

Fang L, Zhang P, Wang K, Xiao Z, Yang M, Yu Z Int J Mol Med. 2019; 43(4):1597-1610.

PMID: 30720050 PMC: 6414172. DOI: 10.3892/ijmm.2019.4090.

Synthesis and evaluation of an F-labeled derivative of F3 for targeting surface-expressed nucleolin in cancer and tumor endothelial cells.

Lam P, Hillyar C, Able S, Vallis K J Labelled Comp Radiopharm. 2016; 59(12):492-499.

PMID: 27594091 PMC: 5082555. DOI: 10.1002/jlcr.3439.

References

Tulchin N, Ornstein L, Bleiweiss I, MENDLOWITZ M, Weinstein E, Dikman S . Nucleolar localization of BRCA1 protein in human breast cancer. Int J Oncol. 1998; 13(3):513-8. View

Scully R, Chen J, Ochs R, Keegan K, Hoekstra M, Feunteun J . Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 1997; 90(3):425-35. DOI: 10.1016/s0092-8674(00)80503-6. View

Budde A, Grummt I . p53 represses ribosomal gene transcription. Oncogene. 1999; 18(4):1119-24. DOI: 10.1038/sj.onc.1202402. View

Ouchi T, Monteiro A, August A, Aaronson S, Hanafusa H . BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A. 1998; 95(5):2302-6. PMC: 19327. DOI: 10.1073/pnas.95.5.2302. View

Momand J, Zambetti G, Olson D, George D, Levine A . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992; 69(7):1237-45. DOI: 10.1016/0092-8674(92)90644-r. View

MONNERON A, Bernhard W . Fine structural organization of the interphase nucleus in some mammalian cells. J Ultrastruct Res. 1969; 27(3):266-88. DOI: 10.1016/s0022-5320(69)80017-1. View

Scully R, Anderson S, Chao D, Wei W, Ye L, Young R . BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A. 1997; 94(11):5605-10. PMC: 20825. DOI: 10.1073/pnas.94.11.5605. View

Rakha E, El-Sheikh S, Kandil M, El-Sayed M, Green A, Ellis I . Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol. 2008; 39(6):857-65. DOI: 10.1016/j.humpath.2007.10.011. View

Shiohama A, Sasaki T, Noda S, Minoshima S, Shimizu N . Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Exp Cell Res. 2007; 313(20):4196-207. DOI: 10.1016/j.yexcr.2007.07.020. View

10.

Guo Z, Qian L, Liu R, Dai H, Zhou M, Zheng L . Nucleolar localization and dynamic roles of flap endonuclease 1 in ribosomal DNA replication and damage repair. Mol Cell Biol. 2008; 28(13):4310-9. PMC: 2447149. DOI: 10.1128/MCB.00200-08. View

11.

Futreal P, Liu Q, Cochran C, Harshman K, Tavtigian S, Bennett L . BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994; 266(5182):120-2. DOI: 10.1126/science.7939630. View

12.

Ozcelik H, To M, Couture J, Bull S, Andrulis I . Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer. 1998; 77(1):1-6. DOI: 10.1002/(sici)1097-0215(19980703)77:1<1::aid-ijc1>3.0.co;2-y. View

13.

Lotti L, Ottini L, DAmico C, Gradini R, Cama A, Belleudi F . Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer. 2002; 35(3):193-203. DOI: 10.1002/gcc.10105. View

14.

Miki Y, Swensen J, Futreal P, Harshman K, Tavtigian S, Liu Q . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182):66-71. DOI: 10.1126/science.7545954. View

15.

Monteiro A . BRCA1: exploring the links to transcription. Trends Biochem Sci. 2000; 25(10):469-74. DOI: 10.1016/s0968-0004(00)01632-7. View

16.

Hadjisavvas A, Mikellidou C, Zenios A, Zouvani I, Adamou A, Christodoulou C . Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases. Ultrastruct Pathol. 2002; 26(4):237-44. DOI: 10.1080/01913120290104494. View

17.

Andersen J, Lyon C, Fox A, Leung A, Lam Y, Steen H . Directed proteomic analysis of the human nucleolus. Curr Biol. 2002; 12(1):1-11. DOI: 10.1016/s0960-9822(01)00650-9. View

18.

Pinol-Roma S . Association of nonribosomal nucleolar proteins in ribonucleoprotein complexes during interphase and mitosis. Mol Biol Cell. 1999; 10(1):77-90. PMC: 25155. DOI: 10.1091/mbc.10.1.77. View

19.

Silver D, Dimitrov S, Feunteun J, Gelman R, Drapkin R, Lu S . Further evidence for BRCA1 communication with the inactive X chromosome. Cell. 2007; 128(5):991-1002. DOI: 10.1016/j.cell.2007.02.025. View

20.

Ganesan S, Silver D, Greenberg R, Avni D, Drapkin R, Miron A . BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell. 2002; 111(3):393-405. DOI: 10.1016/s0092-8674(02)01052-8. View